Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2012 1
2013 2
2014 3
2015 5
2016 2
2017 2
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer.
Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Miyake S, Mikami Ueda M, Yoshida M, Masui K, Yoshioka Y, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka H, Aramoto K, Narumi Y, Yamada S, Tatsumi K, Tanaka E. Yoshida K, et al. Among authors: yoshikawa n. Brachytherapy. 2015 Jan-Feb;14(1):1-8. doi: 10.1016/j.brachy.2014.07.006. Epub 2014 Sep 15. Brachytherapy. 2015. PMID: 25218822
A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer.
Yoshida K, Kotsuma T, Akiyama H, Yamazaki H, Takenaka T, Masui K, Tsujimoto Y, Murakami N, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka H, Nakata M, Arika T, Takaoka Y, Tanaka E, Tselis N. Yoshida K, et al. Among authors: yoshikawa n. J Contemp Brachytherapy. 2019 Dec;11(6):573-578. doi: 10.5114/jcb.2019.91225. Epub 2019 Dec 25. J Contemp Brachytherapy. 2019. PMID: 31969916 Free PMC article.
High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.
Nakata M, Yoshida K, Shimbo T, Yoshikawa N, Yoshioka H, Hori A, Sato C, Uesugi Y, Kogata Y, Masui K, Murakami N, Kashihara T, Akiyama H, Tselis N, Ohmichi M, Nihei K. Nakata M, et al. Among authors: yoshikawa n. J Contemp Brachytherapy. 2020 Dec;12(6):606-611. doi: 10.5114/jcb.2020.101695. Epub 2020 Dec 16. J Contemp Brachytherapy. 2020. PMID: 33437310 Free PMC article.
Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?
Yoshida K, Yamazaki H, Kotsuma T, Takenaka T, Ueda MM, Miyake S, Tsujimoto Y, Masui K, Yoshioka Y, Sumida I, Uesugi Y, Shimbo T, Yoshikawa N, Yoshioka H, Tanaka E, Narumi Y. Yoshida K, et al. Among authors: yoshikawa n. Brachytherapy. 2016 Jan-Feb;15(1):57-64. doi: 10.1016/j.brachy.2015.10.002. Epub 2015 Nov 21. Brachytherapy. 2016. PMID: 26612700
16 results